{"id":891875,"date":"2026-04-13T20:06:15","date_gmt":"2026-04-13T20:06:15","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/891875\/"},"modified":"2026-04-13T20:06:15","modified_gmt":"2026-04-13T20:06:15","slug":"ozempic-14-in-india-vs-349-in-the-us-shorts-youtube","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/891875\/","title":{"rendered":"Ozempic: $14 in India vs. $349 in the US #shorts – YouTube"},"content":{"rendered":"
    \n
  1. Ozempic: $14 in India vs. $349 in the US #shorts<\/a>  YouTube<\/li>\n
  2. Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India<\/a>  CNBC<\/li>\n
  3. India\u2019s generic semaglutide surge<\/a>  Chemistry World<\/li>\n
  4. Ozempic just got cheap enough to change the world<\/a>  vox.com<\/li>\n
  5. Cheaper generics capture 20% of weight-loss mkt<\/a>  The Times of India<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"Ozempic: $14 in India vs. $349 in the US #shorts  YouTube Eli Lilly market share drops, Novo Nordisk holds…\n","protected":false},"author":2,"featured_media":891876,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[4315],"tags":[251833,105,4326,16,15,50863,251832],"class_list":["post-891875","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-explain","tag-health","tag-medication","tag-uk","tag-united-kingdom","tag-vox","tag-vox-com"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/116399203060502619","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/891875","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=891875"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/891875\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/891876"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=891875"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=891875"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=891875"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}